What Wellmicro does

Wellmicro S.r.l. is an Italian biotechnology company founded in 2015 and headquartered in Bologna (operational) and Bussolengo (legal). It operates a specialized laboratory focused exclusively on human microbiota analysis, offering shotgun metagenomic sequencing-based gut and vaginal microbiota tests on the Illumina NovaSeq 6000Dx platform, followed by advanced bioinformatics interpretation that profiles bacteria, fungi (miceti), DNA viruses, and parasites (protozoa and metazoa). Wellmicro holds what it describes as the first Italian patent on a method for analyzing intestinal microbiota data, and positions itself against standardized, one-size-fits-all healthcare by offering personalized microbiome profiling.

The company's commercial portfolio comprises three SKUs sold individually or as a combo: the Wellmicro® Gut Test Plus, the Wellmicro® Vaginal Test, and a combined Gut + Vaginal Combo package. It monetizes through one-time consumer test-kit sales and through professional consulting services for healthcare professionals, primarily physicians (gastroenterologists, gynecologists) and pharmacies.

Distribution is omnichannel within Italy: direct-to-consumer via the e-commerce platform at app.wellmicro.com, through a partnered physician network, and through a partnered pharmacy network, with dedicated "Find a Doctor" and "Find a Pharmacy" locators on the corporate website. Marketing is conducted via the Wellmicro® Academy (scientific publications and educational content for clinicians), corporate social media (LinkedIn, Facebook, Instagram, YouTube), and a Medical News section on the website. The company has also entered co-marketing partnerships with Italian wellness brands Named® and Specchiasol® to advance its personalized-medicine positioning. The team is small (1–10 employees) and the company is privately held with no disclosed institutional funding.

Name

Wellmicro

Legal name

Wellmicro S.r.l.

Website

https://wellmicro.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Wellmicro is an Italian biotech laboratory founded in 2015 that sells shotgun metagenomic gut and vaginal microbiota tests directly to consumers, physicians, and pharmacies in Italy, using patented bioinformatics on the Illumina NovaSeq 6000Dx platform.

Ownership category

akta.pro rank

Product category

Microbiome Diagnostic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)

akta.pro secondary industries

Microbiome & Metagenomics Services (HLAGANAH), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Microbiota testing services
• Metagenomic sequencing analysis
• Gut health diagnostics
• Vaginal microbiome testing
• Bioinformatics laboratory services

Headquarters

HQ city

Bologna

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Microbiota Testing Products: Sale of gut and vaginal microbiota test kits to consumers, healthcare professionals, and pharmacies
2. Professional Consulting Services: Partnership and consulting services for healthcare professionals

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Wellmicro operates a specialized diagnostic laboratory that analyzes human microbiota composition through shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform. The company offers gut and vaginal microbiota test kits that profile bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa), producing reports that compare patient samples against healthy controls and are used to support personalized dietary and therapeutic decisions.

Product overview

Wellmicro is a microbiota-based company offering specialized laboratory tests for analyzing human microbiota composition. The product portfolio consists of two core diagnostic tests—Wellmicro® Gut Test Plus and Wellmicro® Vaginal Test—both using shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform with advanced bioinformatics analysis. These tests are available individually or as a combo package, enabling comprehensive 360-degree microbiota analysis for both intestinal and vaginal samples. The company positions itself as the first in Italy with a patented method for analyzing intestinal microbiota data.

Differentiator

Problem solved

Functional benefit

Brands

• Wellmicro® Gut Test Plus - Metagenomic Revolution: Intestinal microbiota test analyzing bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa) through shotgun sequencing on NovaSeq 6000Dx - Illumina® platform.
• Wellmicro® Vaginal Test - Metagenomic Revolution
• Wellmicro® Academy

Products and services

• Wellmicro® Gut Test Plus - Metagenomic Revolution

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered minor.

• Named®minorStrategic or Co-development PartnerNamed® partnered with Wellmicro® for wellness initiatives, sharing the vision of personalized and precise medicine over standardized approaches.
• Specchiasol®minorStrategic or Co-development PartnerSpecchiasol® partnered with Wellmicro® for wellness initiatives, aligned with the vision of personalized healthcare.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Atlas Biomed: UK-headquartered DTC microbiome testing company offering gut microbiome and DNA testing directly to consumers with personalized health recommendations. Highly comparable to Wellmicro as a DTC-first, sequencing-based microbiota testing brand with a similar consumer+professional proposition.
• Viome Life Sciences: US-based DTC microbiome testing company using metatranscriptomic sequencing to profile gut and oral microbiota and sell personalized nutrition recommendations. Comparable to Wellmicro on technology (high-resolution sequencing), product (microbiome test kits), and go-to-market (DTC + wellness partnerships).
• DayTwo: Microbiome-based personalized nutrition company (Israel/US) that uses gut microbiome profiling to recommend individualized food and glucose responses. Comparable to Wellmicro in applying shotgun microbiome data to clinical/personalized nutrition decisions, though with a B2B payer focus.
• CosmosID: US-based microbiome analytics and sequencing services company offering CLIA-certified gut microbiome testing and bioinformatics platforms for researchers, clinicians, and consumers. Comparable to Wellmicro on shotgun sequencing technology and clinical/professional channel focus, but with a stronger B2B research emphasis.
• Biohm Health: US-based gut and vaginal microbiome testing company selling test kits directly to consumers with personalized nutrition and probiotic recommendations. Directly comparable to Wellmicro on the dual gut + vaginal testing portfolio and DTC model.
• Sun Genomics (Thryve Inside): US-based personalized microbiome company offering whole-genome shotgun sequencing gut tests with custom probiotic formulations. Comparable to Wellmicro on sequencing technology, DTC kit model, and personalized recommendation engine.

Broad incumbents

• ZOE: UK/US personalized nutrition platform combining gut microbiome testing with continuous glucose monitoring and blood fat responses. Comparable to Wellmicro as a consumer-facing gut microbiome testing brand, but operates at a much larger scale with a broader integrated wellness platform.

Regional players

• Microba Life Sciences: Australia-based microbiome profiling and analysis company offering gut microbiome testing to consumers and B2B microbiome analysis services. Comparable to Wellmicro in shotgun metagenomic sequencing methodology and DTC + B2B dual model, but serves the APAC market rather than Europe.

Others

• DNA Genotek (OMNIgene·GUT): Canadian company (part of OraSure Technologies) supplying stool sample collection kits (OMNIgene·GUT) used by microbiome testing labs worldwide. Comparable to Wellmicro as a microbiome sample collection and processing enabler in the same ecosystem.
• Illumina: US-based sequencing platform manufacturer whose NovaSeq 6000Dx platform is the foundational instrument used by Wellmicro for shotgun metagenomic sequencing. Comparable as the key enabling technology vendor in the microbiome sequencing stack that Wellmicro depends on.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@wellmicro214
• Facebookfacebook.com/wellmicro.italia
• LinkedInlinkedin.com/company/wellmicro-s-r-l-
• Instagraminstagram.com/wellmicro_

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellmicro